Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05017012
Title A Study to Evaluate the Bioavailability of Pembrolizumab (MK-3475) Via Subcutaneous (SC) Injection of MK-3475A (Pembrolizumab Formulated With MK-5180) In Advanced Solid Tumors (MK-3475A-C18)
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Merck Sharp & Dohme Corp.
Indications
Therapies
Age Groups: senior | adult
Covered Countries ESP

Facility Status City State Zip Country Details
James Lind Centro de Investigación del Cáncer ( Site 0102) Temuco Araucania 4800827 Chile Details
FALP-UIDO ( Site 0101) Santiago Region M. De Santiago 7500921 Chile Details
Bradfordhill ( Site 0100) Santiago Region M. De Santiago 8420383 Chile Details
Országos Onkológiai Intézet-Urogenital Tumors Department and Clinical Pharmacology ( Site 0021) Budapest Pest 1122 Hungary Details
Magyar Honvedseg Egeszsegugyi Kozpont-Onkologiai Osztaly ( Site 0020) Budapest 1062 Hungary Details
Kansai Medical University Hospital ( Site 0112) Hirakata Osaka 573-1191 Japan Details
Saitama Prefectural Cancer Center ( Site 0110) Ina-machi Saitama 362-0806 Japan Details
Shizuoka Cancer Center ( Site 0111) Nagaizumi-cho,Sunto-gun Shizuoka 411-8777 Japan Details
National Hospital Organization Kyushu Cancer Center ( Site 0114) Fukuoka 811-1395 Japan Details
Osaka International Cancer Institute ( Site 0113) Osaka 541-8567 Japan Details
Severance Hospital, Yonsei University Health System ( Site 0062) Seoul 03722 Korea, Republic of Details
Samsung Medical Center ( Site 0063) Seoul 06351 Korea, Republic of Details
CANCERCARE LANGENHOVEN DRIVE ONCOLOGY CENTRE ( Site 0051) Port Elizabeth Eastern Cape 6055 South Africa Details
Medical Oncology Centre of Rosebank ( Site 0058) Johannesburg Gauteng 2196 South Africa Details
Steve Biko Academic Hospital-Medical Oncology ( Site 0057) Pretoria Gauteng 0001 South Africa Details
LIFE GROENKLOOF-Mary Potter Cancer Centre ( Site 0052) Pretoria Gauteng 0181 South Africa Details
Sandton Oncology Medical Group (Pty) Ltd-Research ( Site 0053) Sandton Gauteng 2196 South Africa Details
Cape Town Oncology Trials ( Site 0050) Cape Town Western Cape 7570 South Africa Details
Cancercare Rondebosch Oncology-Clinical trials ( Site 0055) Rondebosch Western Cape 7700 South Africa Details
Hospital Universitario Virgen de la Victoria-Phase I Trials Unit ( Site 0042) Málaga Andalucia 29010 Spain Details
HOSPITAL CLÍNIC DE BARCELONA-Department of Medical Oncology ( Site 0043) Barcelona Cataluna 08036 Spain Details
HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑON-ONCOLOGY ( Site 0040) Madrid Madrid, Comunidad De 28009 Spain Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field